Header Logo

Connection

Elisa Lee to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Elisa Lee has written about Cost-Benefit Analysis.
Elisa Lee
Connection Strength
0.021
Cost-Benefit Analysis
  1. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) . J Clin Lipidol. 2010 May-Jun; 4(3):165-72.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.